The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Bioengineering bacterial outer membrane vesicles as vaccine platform
Open accessAbstract
Outer membrane vesicles (OMVs) are naturally non-replicating, highly immunogenic spherical nanoparticles derived from Gram-negative bacteria. OMVs from pathogenic bacteria have been successfully used as vaccines against bacterial meningitis and sepsis among others and the composition of the vesicles can easily be engineered. OMVs can be used as a vaccine platform by engineering heterologous antigens to the vesicles. The major advantages of adding heterologous proteins to the OMV are that the antigens retain their native conformation, the ability of targeting specific immune responses, and a single production process suffices for many vaccines. Several promising vaccine platform concepts have been engineered based on decorating OMVs with heterologous antigens. This review discusses these vaccine concepts and reviews design considerations as the antigen location, the adjuvant function, physiochemical properties, and the immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.
Somerville, J. E., Cassiano, L., Bainbridge, B., Cunningham, M. D., & Darveau, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118423 · Cited by 275
Veith, P. D., Chen, Y.-Y., Gorasia, D. G., Chen, D., Glew, M. D., O’Brien-Simpson, N. M., Cecil, J. D., Holden, J. A., & Reynolds, E. C. (2014) · Journal of Proteome Research · doi:10.1021/pr401227e · Cited by 269
Cited by
Cheng, K., Zhao, R., Li, Y., Qi, Y., Wang, Y., Zhang, Y., Qin, H., Qin, Y., Chen, L., Li, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22308-8 · Cited by 480
Bacterial outer membrane vesicles as a platform for biomedical applications: An update
Li, M., Zhou, H., Yang, C., Wu, Y., Zhou, X., Liu, H., & Wang, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.031 · Cited by 370
Biomimetic Nanotechnology toward Personalized Vaccines
Zhou, J., Kroll, A. V., Holay, M., Fang, R. H., & Zhang, L. (2020) · Advanced Materials · doi:10.1002/adma.201901255 · Cited by 328
Cancer nanotechnology: current status and perspectives
Kemp, J. A., & Kwon, Y. J. (2021) · Nano Convergence · doi:10.1186/s40580-021-00282-7 · Cited by 266
Novel approaches for the design, delivery and administration of vaccine technologies
Wallis, J., Shenton, D. P., & Carlisle, R. C. (2019) · Clinical and Experimental Immunology · doi:10.1111/cei.13287 · Cited by 123
Metadata
- Authors
- Gerritzen, M. J. H., Martens, D. E., Wijffels, R. H., van der Pol, L., & Stork, M.
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 35
- Issue
- 5
- Pages
- 565-574
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W2615521039
- Cited by
- 290
- References
- 2
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bioengineering bacterial outer membrane vesicles as vaccine platform. https://app.cochat.ai/papers/10.1016/j.biotechadv.2017.05.003
- The paper
- Gerritzen, M. J. H., Martens, D. E., Wijffels, R. H., van der Pol, L., & Stork, M. (2017). Bioengineering bacterial outer membrane vesicles as vaccine platform. Biotechnology Advances. https://doi.org/10.1016/j.biotechadv.2017.05.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.